Delivery Order SPE2DB25D9357-SPE2DB25FUAGK
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The U.S. Defense Logistics Agency issued a delivery order valued at $67,919.25 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order was awarded on September 15, 2025, without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility. The award represents...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Botox 200 unit vials valued at $7,115.35. This firm fixed-price delivery order represents a single procurement issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and extending through November 2026. The order is set to complete by October 21, 2025, with fulfillment occurring from the vendor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,762.20 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a $2,587.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Botox 200 Unit Vials, with an ultimate completion date of September 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract, valued at $4,625.70 with a firm fixed-price structure, is scheduled for completion by October 9, 2025, and was awarded on September 18, 2025. This delivery order does not utilize a set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite...
- The Defense Logistics Agency awarded a $4,625.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Botox 100 unit vials, with an ultimate completion date of October 17, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $500 million and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, issued under firm fixed-price terms with an ultimate completion date of September 4, 2025, represents a specific purchase order executed without set-aside designation. DMS Pharmaceutical Group, registered in the System for Award Management since...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $2,587.40, is set to be completed by September 17, 2025, and will be fulfilled from the vendor's location in Park Ridge, Illinois. The award represents a discrete purchase order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB pharmaceutical supply...
- SPE2DB25D9357Indefinite Delivery Contract
- SPE2DB25D9357-SPE2DB25FUAGKDelivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $19,405.50 on August 21, 2025, for the supply of Botox 200 Unit Vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 12, 2025. The contract employs firm fixed-price pricing with no set-aside designation, allowing the vendor to compete directly in the federal marketplace. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for specialty medications and medical supplies to Department of Defense healthcare sites. The company's portfolio includes an extensive range of pharmaceutical products spanning branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. This particular delivery order for Botox reflects the vendor's ongoing role in supplying specialty pharmaceutical products to federal healthcare systems, supporting the Defense Logistics Agency's mission to maintain adequate medical supply levels across military facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 8/21/25 |